Loading clinical trials...
Loading clinical trials...
Phase III, Double-blind, Placebo-controlled, Randomized, 1-month Clinical Trial of Immunoxel Combined With Anti-TB Therapy Versus Anti-TB Therapy With Placebo
Conditions
Interventions
Immunoxel
Placebo
Locations
2
Mongolia
Misheel Lung surgery hospital,
Ulaanbaatar, Ulaanbaatar, Mongolia
Kharkiv Medical National University
Kharkiv, Ukraine, Ukraine
Start Date
January 1, 2010
Primary Completion Date
March 1, 2015
Completion Date
April 1, 2015
Last Updated
May 20, 2015
NCT01875588
NCT04929028
NCT07071623
NCT03087253
NCT06192160
NCT07199335
Lead Sponsor
Lisichansk Regional Tuberculosis Dispensary
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions